V020-2239 Screening compound: benzyl[2-hydroxy-3-(propan-2-yloxy)propyl]{2-[3-(3,4,5-trimethoxyphenyl)-1,2,4-oxadiazol-5-yl]ethyl}amine

V020-2239 Screening compound: benzyl[2-hydroxy-3-(propan-2-yloxy)propyl]{2-[3-(3,4,5-trimethoxyphenyl)-1,2,4-oxadiazol-5-yl]ethyl}amine
V020-2239 Screening compound: benzyl[2-hydroxy-3-(propan-2-yloxy)propyl]{2-[3-(3,4,5-trimethoxyphenyl)-1,2,4-oxadiazol-5-yl]ethyl}amine alternative view

Chemical Structure Depiction of ChemDiv screening compound V020-2239
benzyl[2-hydroxy-3-(propan-2-yloxy)propyl]{2-[3-(3,4,5-trimethoxyphenyl)-1,2,4-oxadiazol-5-yl]ethyl}amine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V020-2239

Molecular Formula

C26H35N3O6 (C26 H35 N3 O6)

Compound Name

benzyl[2-hydroxy-3-(propan-2-yloxy)propyl]{2-[3-(3,4,5-trimethoxyphenyl)-1,2,4-oxadiazol-5-yl]ethyl}amine

IUPAC name

benzyl[2-hydroxy-3-(propan-2-yloxy)propyl]{2-[3-(345-trimethoxyphenyl)-124-oxadiazol-5-yl]ethyl}amine

SMILES

CC(C)OCC(CN(CCc1nc(-c(cc2OC)cc(OC)c2OC)no1)Cc1ccccc1)O

InChI

InChI=1S/C26H35N3O6/c1-18(2)34-17-21(30)16-29(15-19-9-7-6-8-10-19)12-11-24-27-26(28-35-24)20-13-22(31-3)25(33-5)23(14-20)32-4/h6-10,13-14,18,21,30H,11-12,15-17H2,1-5H3/t21-/m0/s1

InChI Key

OHZIIYLPDOCOOH-NRFANRHFSA-N

MDL Number (MFCD)

MFCD19870523

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

485.58

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

14.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.783

Distribution Coefficient, logD

3.656

Water Solubility, LogSw

-3.97

Polar Surface Area

82.151

Acid Dissociation Constant (pKa)

14.75

Base Dissociation Constant (pKb)

6.93

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

46.20

V020-2239 in Drug Discovery

Included in Screening Libraries

MCL1 Targeted Library (12200 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic

References: we are preparing a list of scientific research reports with V020-2239 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V020-2239?
Check Price and Availability of V020-2239, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V020-2239 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V020-2239
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V020-2239
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V020-2239 available by request